Please login to the form below

Not currently logged in
Email:
Password:

MedTera launches in New York

An integrated marketing solutions company, MedTera, has launched in New York

An integrated marketing solutions company, MedTera, dedicated to improving education, promotion and communications in the healthcare, life sciences and pharmaceutical industries, has launched in New York.

The company specialises in the design and execution of comprehensive integrated marketing programmes for healthcare marketers and their agencies, to help develop more successful relationships with patients, care givers and physicians. 

"Our mission is to provide pharmaceutical marketers with the newest dimension in education, communication, promotion and analytics," said David Duplay, president of MedTera. 

"Patient and physician education is more important now than ever before, meaning the job of marketers in this industry is critical. Our innovative approach and solutions provide organisations with the tools necessary to positively impact the enrichment of people's lives."

By partnering with other industry-leading organisations, MedTera creates cutting-edge marketing programmes that will enable clients to optimise their investments in the development, promotion and delivery of healthcare products and services.

MedTera offers full-service solutions that are highly interactive and incorporate physical and digital media components. This dynamic experience engages audiences, ensuring greater brand awareness, improved patient compliance, expanded market share and increased ROI. 

MedTera is a wholly owned subsidiary of Structural Graphics, which has 30+ years experience of offering marketing solutions.  

14th January 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics